These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1268491)

  • 41. Development and validation of a recirculatory physiological model of the myocardial concentrations of lignocaine after intravenous administration in sheep.
    Upton RN; Zheng DA; Grant C; Martinez AM
    J Pharm Pharmacol; 2000 Feb; 52(2):181-9. PubMed ID: 10714948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Arterial oxygen and carbon-dioxide tension in patients with acute myocardial infarction.
    Helmers C; Hofvendahl S; Lundman T; Mogensen L; Nyquist O; Säwe U; Wester P
    Cardiology; 1973; 58(6):335-46. PubMed ID: 4803002
    [No Abstract]   [Full Text] [Related]  

  • 43. [Dynamics of interleukin 6 levels in the patients with cardiogenic and septic shock and in a control group of patients with uncomplicated AMI].
    Pařenica J; Maláska J; Jarkovský J; Helánová K; Jabandžiev P; Michálek J; Veselková Z; Littnerová S; Kubková L; Gál R; Sevčík P; Goldbergová MP; Litzman J; Čermáková Z; Špinar J
    Vnitr Lek; 2014 Feb; 60(2):114-22. PubMed ID: 24754415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of lignocaine in children following caudal anaesthesia.
    Ecoffey C; Desparmet J; Berdeaux A; Maury M; Giudicelli JF; Saint-Maurice C
    Br J Anaesth; 1984 Dec; 56(12):1399-402. PubMed ID: 6498050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma lignocaine levels during transurethral prostatectomy.
    Eardley I; Broome GD; Murray A; Ramsay JW; Whitfield HN; Wilkinson DJ
    Ann R Coll Surg Engl; 1989 Sep; 71(5):278-80. PubMed ID: 2802473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lignocaine: a new technique for intravenous administration.
    Levy RA; Charuzi Y; Mandel WJ
    Br Heart J; 1977 Sep; 39(9):1026-8. PubMed ID: 907767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition.
    Bax ND; Tucker GT; Lennard MS; Woods HF
    Br J Clin Pharmacol; 1985 May; 19(5):597-603. PubMed ID: 2860914
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between alpha 1-acid glycoprotein and lidocaine disposition in myocardial infarction.
    Routledge PA; Shand DG; Barchowsky A; Wagner G; Stargel WW
    Clin Pharmacol Ther; 1981 Aug; 30(2):154-7. PubMed ID: 7249498
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prevention, clinical aspects and therapy of the side-effects of lidocaine].
    Kettner W; Lenz M; Kettner E; Banditt P; Walther H
    Z Gesamte Inn Med; 1984 Oct; 39(20):501-5. PubMed ID: 6516492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinetic predictive techniques applied to lignocaine therapeutic drug monitoring.
    Joel SE; Bryson SM; Small M; Hillis WS; Kelman AW; Whiting B
    Ther Drug Monit; 1983; 5(3):271-7. PubMed ID: 6636255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppressed MMP-9 Activity in Myocardial Infarction-Related Cardiogenic Shock Implies Diminished Rage Degradation.
    Selejan SR; Hewera L; Hohl M; Kazakov A; Ewen S; Kindermann I; Böhm M; Link A
    Shock; 2017 Jul; 48(1):18-28. PubMed ID: 28608784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Blood lactic acid, blood pyruvate and lactate excess in patients with acute myocardial infarct].
    Ferro L; Meaney E; Calva E; Malpartida F; Froufe J; Cárdenas M
    Arch Inst Cardiol Mex; 1973; 43(5):757-65. PubMed ID: 4761966
    [No Abstract]   [Full Text] [Related]  

  • 53. Changes in lignocaine disposition during long-term infusion in patients with acute ventricular arrhythmias.
    Thomson AH; Kelman AW; de Vane PJ; Hillis WS; Whiting B
    Ther Drug Monit; 1987 Sep; 9(3):283-91. PubMed ID: 3672571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myocardial uptake of lignocaine: pharmacokinetics and pharmacodynamics in the isolated perfused heart of the rabbit.
    Mazoit JX; Kantelip JP; Orhant EE; Talmant JM
    Br J Pharmacol; 1990 Dec; 101(4):843-6. PubMed ID: 2085708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Processes of oxidation-reduction and adhesiveness and agreggation of thrombocytes in complications of acute myocardial infarct].
    Orlova NP; Lokhvitskaia NL; Volodin EE
    Ter Arkh; 1978; 50(4):12-6. PubMed ID: 663831
    [No Abstract]   [Full Text] [Related]  

  • 56. Rapid prediction of individual dosage requirements for lignocaine.
    Vozeh S; Berger M; Wenk M; Ritz R; Follath F
    Clin Pharmacokinet; 1984; 9(4):354-63. PubMed ID: 6467768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variability of early lidocaine levels in patients.
    Zito RA; Reid PR; Longstreth JA
    Am Heart J; 1977 Sep; 94(3):292-6. PubMed ID: 888762
    [No Abstract]   [Full Text] [Related]  

  • 58. Plasma-hydrocortisone values in heart disease. Results after acute myocardial infarction (with and without cardiogenic shock) and in patients with congestive heart failure.
    Hansen B; Beck-Nielsen J; Juul J; Nielsen BL; Nielsen FU
    Acta Med Scand; 1969 Nov; 186(5):411-6. PubMed ID: 5378341
    [No Abstract]   [Full Text] [Related]  

  • 59. Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarction.
    Fellner B; Rohla M; Jarai R; Smetana P; Freynhofer MK; Egger F; Zorn G; Weiss TW; Huber K; Geppert A
    Eur Heart J Acute Cardiovasc Care; 2017 Jun; 6(4):348-358. PubMed ID: 26936869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simple lignocaine regimen for transit to hospital after myocardial infarction.
    Barber JM; Boyle DM; Hussain Z; McDevitt DG
    Br Heart J; 1977 Dec; 39(12):1361-3. PubMed ID: 603738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.